These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 30594167

  • 21. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q, Shi S, Wang S, Ren Y, Hou W, Liu L, Lv J, Haas M, Zhang H.
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [Abstract] [Full Text] [Related]

  • 22. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Nov; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 23. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 Nov; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]

  • 24. Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study.
    Xia M, Liu D, Peng L, Li Y, Liu H, Wu L, Chen G, Liu Y, Liu H.
    BMC Nephrol; 2020 Oct 27; 21(1):447. PubMed ID: 33109129
    [Abstract] [Full Text] [Related]

  • 25. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy.
    Zhai Y, Sun S, Zhang W, Tian H.
    Ren Fail; 2024 Dec 27; 46(2):2381613. PubMed ID: 39039867
    [Abstract] [Full Text] [Related]

  • 26. Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy.
    Hwang JH, Lee JP, Kim CT, Yang SH, Kim JH, An JN, Moon KC, Lee H, Oh YK, Joo KW, Kim DK, Kim YS, Lim CS.
    Am J Nephrol; 2016 Dec 27; 44(6):481-492. PubMed ID: 27802442
    [Abstract] [Full Text] [Related]

  • 27. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B, Zhou W, Cui L, Tian L, Ni Y, Yang M, Yang Y.
    Front Endocrinol (Lausanne); 2024 Dec 27; 15():1372824. PubMed ID: 38808109
    [Abstract] [Full Text] [Related]

  • 28. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC, Pinheiro SV, de Almeida Araújo S, Simões E Silva AC.
    Nephrology (Carlton); 2016 Dec 27; 21(12):995-1002. PubMed ID: 27414046
    [Abstract] [Full Text] [Related]

  • 29. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B, Zhao L, Yang Q, Zha D, Si X.
    Int Urol Nephrol; 2021 Nov 27; 53(11):2321-2332. PubMed ID: 33895976
    [Abstract] [Full Text] [Related]

  • 30. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
    Guan J, Wang M, Zhao M, Ni W, Zhang M.
    BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570
    [Abstract] [Full Text] [Related]

  • 31. Characteristics of IgA nephropathy in advanced-age patients.
    Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K.
    Int Urol Nephrol; 2015 Jan 20; 47(1):137-45. PubMed ID: 25388352
    [Abstract] [Full Text] [Related]

  • 32. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Jan 20; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 33. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May 20; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 34. Clinical, pathological characteristics and outcomes of immunoglobulin A nephropathy patients with different ages.
    Wen Q, Rong R, Zhou Q, Tang X, Yang Q, Chen W, Yu X.
    Nephrology (Carlton); 2020 Dec 20; 25(12):906-912. PubMed ID: 31576628
    [Abstract] [Full Text] [Related]

  • 35. Influences of renal anemia on the pathology of IgA nephropathy: a study based on propensity score matching.
    Li F, Wei RB, Wang Y, Su TY, Li QP, Li P, Chen XM.
    Discov Med; 2020 Dec 20; 30(159):7-18. PubMed ID: 33357358
    [Abstract] [Full Text] [Related]

  • 36. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E.
    Nefrologia (Engl Ed); 2019 Dec 20; 39(5):523-530. PubMed ID: 30902505
    [Abstract] [Full Text] [Related]

  • 37. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Dec 20; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 38. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T, Joh K, Okonogi H, Koike K, Utsunomiya Y, Miyazaki Y, Matsushima M, Yoshimura M, Horikoshi S, Suzuki Y, Furusu A, Yasuda T, Shirai S, Shibata T, Endoh M, Hattori M, Katafuchi R, Hashiguchi A, Kimura K, Matsuo S, Tomino Y, Study Group Special IgA Nephropathy.
    J Nephrol; 2013 Dec 20; 26(2):350-7. PubMed ID: 22684645
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.
    Pediatr Nephrol; 2017 Jan 20; 32(1):139-150. PubMed ID: 27557557
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
    Liu S, Lu Z, Fu Z, Li H, Gui C, Deng Y.
    Kidney Blood Press Res; 2023 Jan 20; 48(1):186-193. PubMed ID: 37062274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.